Sign up to save your podcasts
Or
Share Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Dr Joshua Brody from The Tisch Cancer Institute in New York, Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha and Dr Jason Westin from The University of Texas MD Anderson Cancer Center in Houston discuss chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6969 ratings
Dr Joshua Brody from The Tisch Cancer Institute in New York, Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha and Dr Jason Westin from The University of Texas MD Anderson Cancer Center in Houston discuss chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia.
CME information and select publications here.
More shows like Hematologic Oncology Update
View all
JAMA Editors' Summary
130 Listeners
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
32 Listeners
Prostate Cancer Update
15 Listeners
Breast Cancer Update
65 Listeners
Gynecologic Oncology Update
11 Listeners
Dermatologic Oncology Update
0 Listeners
NEJM This Week
324 Listeners
Research To Practice | Oncology Videos
113 Listeners
The Hematologist
26 Listeners
JAMA Clinical Reviews
492 Listeners
Annals On Call Podcast
185 Listeners
Blood Podcast
51 Listeners
Oncology Today with Dr Neil Love
52 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
169 Listeners
Blood Cancer Talks
48 Listeners